Jason Li

Massachusetts Institute of Technology

Papers

1

Total Citations

52

H-Index

1

About

Jason Li is a pioneer in bioinspired drug delivery, with his research focusing on the intersection of soft robotics, gastrointestinal engineering, and biomimetic design. His most notable contribution is the development of cephalopod-inspired jetting devices for gastrointestinal drug delivery, a breakthrough that reimagines how macromolecular therapies—such as insulin or monoclonal antibodies—can be administered without needles. By mimicking the jet-propulsion mechanisms of squid and octopuses, Li’s ingestible robotic platform achieves targeted, high-pressure injection directly into GI tissue, eliminating the need for sharps, specialized training, or disposal protocols. This work, published in 2024 and already garnering 52 citations, addresses a critical bottleneck in oral biologics delivery: the inability to safely and effectively transport large molecules across the gut lining. Li’s innovation bridges soft robotics and clinical medicine, offering a painless, patient-friendly alternative to traditional injections. His research has been recognized for its translational potential, with implications for diabetes care, vaccine delivery, and chronic disease management. For students and researchers, Li exemplifies how observing nature’s engineering can solve real-world medical challenges, turning a squid’s jet into a tool for needle-free healthcare.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Cephalopod-inspired jetting devices for gastrointestinal drug delivery
52 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Massachusetts Institute of Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago